JC Viruria Is Associated With Reduced Risk of Diabetic Kidney Disease.

PURPOSE African Americans who shed JC polyomavirus (JCV) in their urine have reduced rates of nondiabetic chronic kidney disease (CKD). We assessed the associations between urinary JCV and urine BK polyomavirus (BKV) with CKD in African Americans with diabetes mellitus. METHODS African Americans with diabetic kidney disease (DKD) and controls lacking nephropathy from the Family Investigation of Nephropathy and Diabetes Consortium (FIND) and African American-Diabetes Heart Study (AA-DHS) had urine tested for JCV and BKV using quantitative PCR. Of the 335 individuals tested, 148 had DKD and 187 were controls. RESULTS JCV viruria was detected more often in the controls than in the patients with DKD (FIND: 46.6% vs 32.2%; OR, 0.52; 95% CI, 0.29 to 0.93; P = 0.03; AA-DHS: 30.4% vs 26.2%; OR, 0.63; 95% CI, 0.27 to 1.48; P = 0.29). A joint analysis adjusted for age, sex, and study revealed that JC viruria was inversely associated with DKD (OR, 0.56; 95% CI, 0.35 to 0.91; P = 0.02). Statistically significant relationships between BKV and DKD were not observed. MAIN CONCLUSIONS The results from the present study extend the inverse association between urine JCV and nondiabetic nephropathy in African Americans to DKD. These results imply that common pathways likely involving the innate immune system mediate coincident chronic kidney injury and restriction of JCV replication. Future studies are needed to explore causative pathways and characterize whether the absence of JC viruria can serve as a biomarker for DKD in the African American population.

[1]  C. Langefeld,et al.  Protective association between JC polyoma viruria and kidney disease , 2019, Current opinion in nephrology and hypertension.

[2]  C. Langefeld,et al.  JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  K. Skorecki,et al.  "Biomarking" the transition from genetic risk to kidney disease. , 2018, Kidney international.

[4]  R. Do,et al.  Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants. , 2018, Kidney international.

[5]  K. Skorecki,et al.  APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story. , 2017, Seminars in nephrology.

[6]  M. Buck,et al.  APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8. , 2017, JCI insight.

[7]  Patrick D. Dummer,et al.  Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice , 2017, Nature Medicine.

[8]  B. O'Hara,et al.  JC Polyomavirus Infection of Primary Human Renal Epithelial Cells Is Controlled by a Type I IFN-Induced Response , 2016, mBio.

[9]  Dermot F. Reilly,et al.  Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort. , 2016, Journal of the American Society of Nephrology : JASN.

[10]  Catherine C. Robertson,et al.  Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects. , 2016, Journal of the American Society of Nephrology : JASN.

[11]  Benjamin J. Keller,et al.  Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND) , 2015, PLoS genetics.

[12]  Sophie Limou,et al.  APOL1 Kidney Disease Risk Variants: An Evolving Landscape. , 2015, Seminars in nephrology.

[13]  M. Ramsay,et al.  APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans. , 2015, Journal of the American Society of Nephrology : JASN.

[14]  V. D’Agati,et al.  Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 , 2014, Kidney international.

[15]  Nicholette D. Palmer,et al.  APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes , 2014, Kidney international.

[16]  K. Skorecki,et al.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[17]  A. Rubio-Guerra,et al.  Diabetic nephropathy and inflammation. , 2014, World journal of diabetes.

[18]  R. Bosch,et al.  Plasma apolipoprotein L1 levels do not correlate with CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[19]  J. Kopp JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene × environment interaction? , 2013, Kidney international.

[20]  M. Rocco,et al.  JC polyoma virus interacts with APOL1 in African Americans with non-diabetic nephropathy , 2013, Kidney international.

[21]  A. Vallinoto,et al.  Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease , 2011, Transplant infectious disease : an official journal of the Transplantation Society.

[22]  G. Genovese,et al.  Population-based risk assessment of APOL1 on renal disease. , 2011, Journal of the American Society of Nephrology : JASN.

[23]  J. O'Toole,et al.  APOL1 localization in normal kidney and nondiabetic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[24]  H. Anders,et al.  Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. , 2011, Kidney international.

[25]  Giulio Genovese,et al.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[26]  E. Major,et al.  Inhibitory interactions between BK and JC virus among kidney transplant recipients. , 2011, Journal of the American Society of Nephrology : JASN.

[27]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[28]  S. Rosset,et al.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.

[29]  H. Anders,et al.  Interferon-alpha and -beta in kidney inflammation. , 2010, Kidney international.

[30]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[31]  Adrian Egli,et al.  Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. , 2009, The Journal of infectious diseases.

[32]  B. O'Hara,et al.  Invasion of Host Cells by JC Virus Identifies a Novel Role for Caveolae in EndosomalSorting of Noncaveolar Ligands , 2006, Journal of Virology.

[33]  W. Knowles Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). , 2006, Advances in experimental medicine and biology.

[34]  Kristina Doerries Human polyomavirus JC and BK persistent infection. , 2006, Advances in experimental medicine and biology.

[35]  W. Atwood,et al.  The human polyomaviruses , 2006, Cellular and Molecular Life Sciences CMLS.

[36]  G. Silvestri Naturally SIV‐infected sooty mangabeys: are we closer to understanding why they do not develop AIDS? , 2005, Journal of medical primatology.

[37]  R. Elston,et al.  The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. , 2005, Journal of diabetes and its complications.

[38]  A. Tenório,et al.  Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  P. Klapper,et al.  Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[40]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[41]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[42]  D. Pillay,et al.  Prevalence of long‐term BK and JC excretion in HIV‐infected adults and lack of correlation with serological markers , 1999, Journal of medical virology.

[43]  J. Cohen,et al.  Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. , 1993, The Journal of infectious diseases.

[44]  T. Miyamura,et al.  Prevalence Rate and Age of Acquisition of Antibodies against JC Virus and BK Virus in Human Sera , 1982, Microbiology and immunology.